Back to Search
WILLIAM BREMNER, MD
MD
Endocrinology, Diabetes & Metabolism Physician
NPI: 1518042316Individual
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
MD00016365(WA)
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
MD00016365(WA)
Research & Publications (20)
Oral administration of the GnRH antagonist acyline, in a GIPET-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics.
PMID 19479252·Cancer Chemother Pharmacol·2009
2-rct
Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
PMID 19366848·J Clin Endocrinol Metab·2009
4-observational
Long-term outcome studies of testosterone therapy in older hypogonadal men: waiting for Godot?
PMID 19020524·Nat Clin Pract Endocrinol Metab·2008
8-other
Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study.
PMID 18097527·Asian J Androl·2008
8-other
The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men.
PMID 18423697·J Urol·2008
4-observational
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.
PMID 18303073·J Clin Endocrinol Metab·2008
8-other
Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin.
PMID 17462643·Fertil Steril·2008
2-rct
The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men.
PMID 17299062·J Clin Endocrinol Metab·2007
4-observational
Sex steroids and all-cause and cause-specific mortality in men.
PMID 17592098·Arch Intern Med·2007
8-other
Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.
PMID 17303493·Contraception·2007
8-other
Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer.
PMID 17510436·Cancer Res·2007
3-trial
Miglustat has no apparent effect on spermatogenesis in normal men.
PMID 17067996·Hum Reprod·2007
8-other
Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease.
PMID 16431254·Am J Kidney Dis·2006
3-trial
Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men.
PMID 16731547·Hum Reprod·2006
2-rct
Persistent intraprostatic androgen concentrations after medical castration in healthy men.
PMID 16882745·J Clin Endocrinol Metab·2006
2-rct
The androgen receptor gene CAG repeat polymorphism does not predict increased risk of heart disease: longitudinal results from the Massachusetts Male Ageing Study.
PMID 16918952·Clin Endocrinol (Oxf)·2006
8-other
Drug insight: Recent advances in male hormonal contraception.
PMID 16932251·Nat Clin Pract Endocrinol Metab·2006
6-review
Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.
PMID 16940442·J Clin Endocrinol Metab·2006
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MEDICAL SPECIALTIES-ENDOCRINE CLIN, 1959 NE PACIFIC STREET
SEATTLE, WA 98195 - Phone
- (206) 598-4615
Quick Facts
- NPI
- 1518042316
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile